Hospira, Inc. First Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Hospira, Inc. (NYSE:HSP) will unveil its latest earnings on Tuesday, May 1, 2012. Hospira is a global specialty pharmaceutical and medication delivery company that develops products that help improve the safety and productivity of patient care.

Hospira, Inc. Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for profit of 46 cents per share, a decline of 50.5% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 50 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 46 cents during the last month. For the year, analysts are projecting net income of $2.17 per share, a decline of 28.6% from last year.

Past Earnings Performance: Last quarter, the company topped estimates by 0 cents, coming in at profit of 51 cents per share against a mean estimate of net income of 45 cents. The company fell in line with estimates in the third quarter of the last fiscal year.

Investing Insights: What’s the Future of Microsoft’s Stock?

Wall St. Revenue Expectations: On average, analysts predict $951 million in revenue this quarter, a decline of 4.9% from the year-ago quarter. Analysts are forecasting total revenue of $4.01 billion for the year, a decline of 1.2% from last year’s revenue of $4.06 billion.

Analyst Ratings: Analysts seem relatively indifferent about Hospira with eight of 14 analysts surveyed maintaining a hold rating.

A Look Back: In the fourth quarter of the last fiscal year, the company swung to a loss of $214 million ($1.27 a share) from a profit of $60.6 million (36 cents) a year earlier, but beat analyst expectations. Revenue rose 2.2% to $1.01 billion from $992.1 million.

Key Stats:

On the top line, the company is looking to build on three-straight revenue increases heading into this earnings announcement. Revenue increased 9.9% in the second quarter of the last fiscal year and 2.9% in the third quarter of the last fiscal year before climbing again in the fourth quarter of the last fiscal year of the last fiscal year.

Stock Price Performance: Between March 27, 2012 and April 25, 2012, the stock price dropped $3.12 (-8.2%), from $38.14 to $35.02. The stock price saw one of its best stretches over the last year between August 25, 2011 and September 1, 2011, when shares rose for six straight days, increasing 5.6% (+$2.45) over that span. It saw one of its worst periods between September 14, 2011 and September 22, 2011 when shares fell for seven straight days, dropping 13.1% (-$5.21) over that span.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Don’t Miss These Additional Hot Stories:

The Procter & Gamble Company Third Quarter Earnings Sneak Peek>>

Apple Pounds Critics into Applesauce>>

Gold & Silver: Ben Bernanke Overshadows FOMC Minutes>>